Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Market Cap	35.05M
Revenue (ttm)	15.71M
Net Income (ttm)	-26.16M
Shares Out	1.06B
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400,000
Average Volume	364,010
Open	0.0300
Previous Close	0.0350
Day's Range	0.0300 - 0.0340
52-Week Range	0.0260 - 0.0900
Beta	n/a
RSI	55.01
Earnings Date	Oct 29, 2025

About SGXC:9G2

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and ima...

• Industry: Medical Laboratories
• Founded: 2011
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 9G2

Financial Performance

In 2025, SGXC:9G2's revenue was 15.71 million, a decrease of -5.63% compared to the previous year's 16.65 million. Losses were -26.16 million, -30.14% less than in 2024.